| 000 | 01845 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514042233.0 | ||
| 264 | 0 | _c20020918 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a0022-5347 | ||
| 024 | 7 |
_a10.1016/S0022-5347(05)64550-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNeri, B | |
| 245 | 0 | 0 |
_aPhase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer. _h[electronic resource] |
| 260 |
_bThe Journal of urology _cSep 2002 |
||
| 300 |
_a956-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Neoplasms _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aDoni, L | |
| 700 | 1 | _aGemelli, M T | |
| 700 | 1 | _aFulignati, C | |
| 700 | 1 | _aTurrini, M | |
| 700 | 1 | _aDi Cello, V | |
| 700 | 1 | _aDominici, A | |
| 700 | 1 | _aMaleci, M | |
| 700 | 1 | _aMottola, A | |
| 700 | 1 | _aPonchietti, R | |
| 700 | 1 | _aRaugei, A | |
| 700 | 1 | _aValsuani, G | |
| 700 | 1 | _aCini, G | |
| 773 | 0 |
_tThe Journal of urology _gvol. 168 _gno. 3 _gp. 956-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0022-5347(05)64550-8 _zAvailable from publisher's website |
| 999 |
_c12069453 _d12069453 |
||